Cost-benefit analysis of biomarker-driven early detection of pancreatic cancer in individuals with new-onset diabetes

Irena Stefanova^*, Nathan Thompson, Martyn Stott, Lucy Oldfield, Robert Hanson, Robert van der Meer, Daniel Palmer, William Greenhalf, Christopher Halloran, Eithne Costello

^*Corresponding author for this work

Management Science

Research output: Contribution to conference › Poster › peer-review

6 Downloads (Pure)

2 Invited talk
1 Media Participation

3 results
- Title
- Start date(ascending)

Data Science in understanding cancer: hands-on examples
van der Meer, R. (Invited speaker)
7 Feb 2023
Activity: Talk or Presentation › Invited talk
Cost-effectiveness & socio-economic implications of screening individuals with new onset diabetes for pancreatic cancer
van der Meer, R. (Speaker)
20 Nov 2019
Activity: Talk or Presentation › Invited talk
Interview on STV News on early diagnosis of pancreatic cancer
van der Meer, R. (Interviewee) & McKay, C. J. (Interviewee)
1 May 2019
Activity: Public Engagement and Outreach › Media Participation